Headlines > All Regulatory & Safety News
India to get first protein manufacturing plant?
24-Mar-2004 - US-based biotechnology company Human Genome Sciences is planning to set up the first protein manufacturing facility in India in collaboration with local companies.
Novartis hangs back from Aventis bid
24-Mar-2004 - Switzerland's Novartis has confirmed that it is interested in joining with Aventis, but will not proceed with a formal bid unless the French government draws back from its hostile stance on a link-up, reports Phil Taylor.
For a new drug, just click here!
24-Mar-2004 - Researchers in France and the US have used a technique known as click chemistry to discover potent new inhibitors of acetylcholinesterase, an enzyme that serves as a drug target in Alzheimer's disease, writes Phil Taylor.
EC mulls fast track 'scientific visa'
23-Mar-2004 - Proposals to introduce a 'scientific visa' to facilitate movement of third country researchers to and within the EU have been adopted by the European Commission, writes Wai Lang Chu.
Testing drugs in tiny volumes
22-Mar-2004 - A new machine from Ultrasonic Scientific promises to revolutionise the analysis of chemical reactions by requiring only a tiny amount of sample, an important consideration when testing expensive biologic compounds.
Academics embrace high-throughput screening
22-Mar-2004 - A brand new chemical genomics facility, one of the first academic small molecule screening facilities in Europe, has been opened by the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Centre (DKFZ) in Heidelberg, Germany, writes Wai Lang Chu.
Chinese chemical industry heads for consolidation?
22-Mar-2004 - Compared with European and US chemical companies, most domestic Chinese chemical enterprises have remained technologically challenged with productivity lagging behind international levels.
Scientist decline could hamper UK R&D
19-Mar-2004 - The pharmaceutical industry in the UK could face a recruitment crisis if more is not done to encourage students to opt for science and engineering courses, according to the Association of the British Pharmaceutical Industry.
FDA to seek answer to pipeline blockage
18-Mar-2004 - The US Food and Drug Administration is to develop a blueprint for speeding up the approval of new medical products to counteract the slowdown in R&D productivity in the pharmaceutical industry.
NewCo will be called Lanxess, says Bayer
18-Mar-2004 - Germany chemical and pharmaceutical company Bayer has christened its chemicals spin-off Lanxess, and says it is on schedule for a stock market flotation early next year.
Merger creates new force in life sciences
18-Mar-2004 - Fisher Scientific and Apogent Technologies are to merge in a $3.7 billion (€3.01bn) deal that will double Fisher's footprint in the high-growth life sciences equipment market, reports Phil Taylor.
UK govt and industry unveil R&D investment
18-Mar-2004 - The UK government has promised to protect the large funding increases for science announced in the country's last Spending Review and pledged more investment under a new 10-year strategy for science.
BASF optimistic about '04 outlook
17-Mar-2004 - German chemicals giant BASF has beaten its own sales and earnings forecasts for 2003, prompting chairman Jurgen Hambrecht to suggest that the sector may be due for something of a recovery this year.
Inhaler pact answers FDA mandate
17-Mar-2004 - Regulatory demands in the US aimed at improving the devices used to deliver inhaled drugs have spurred an agreement that could see Bespak's specialised inhalers rolled out across the world.
After difficult year, Tecan sees no recovery in early 04
15-Mar-2004 - Switzerland's Tecan saw its sales last year fall 6 per cent as turnover growth in its genomics/proteomics division failed to counterbalance declines in drug discovery and diagnostics.
Excipients coming out of API shadow?
15-Mar-2004 - New active ingredients are the lifeblood of the pharmaceutical industry, but with the number of new compounds being launched tailing off almost yearly, companies are turning to inactive excipients as a source of product innovation, writes Phil Taylor.
Novartis considering white knight bid for Aventis
15-Mar-2004 - Switzerland's Novartis has confirmed that it is in discussions with Aventis which could lead to a counter-offer to fend off the hostile takeover bid from France's Sanofi-Synthelabo.
Flowmeter use rising on legislative pressure
15-Mar-2004 - The need to conform with new European Commission (EC) regulations and the increasing demand for improved efficiency in process industries are encouraging greater adoption of flowmeters.
Crucell buys protein production firm
11-Mar-2004 - Biotechnology company Crucell has acquired fellow Netherlands-based ChromaGenics in a move to get hold of a promising new technology that could boost yields of proteins and antibodies made in cell culture, writes Phil Taylor.
Instrumentation maker adds service business
10-Mar-2004 - MOCON has decided to expand out of its primary business of manufacturing instrumentation and break into new territory in providing testing and consulting services.
Hungarian govt to sell Richter stake?
10-Mar-2004 - The Hungarian government is considering selling its quarter-share of pharmaceutical manufacturer Richter Gedeon in a move that could see a strategic investor taking a sizeable stake in the firm.
Taiyo is latest Japanese firm to hike contract manufacturing
10-Mar-2004 - Japan's Taiyo Pharmaceutical Industry is planning to increase its contract manufacturing operations in the wake of new government legislation that makes it easier for firms to produce drugs for third parties.
Restructuring eats into profits at leading chemicals group
09-Mar-2004 - A fall in demand from the pharmaceuticals industry has caused a significant hole in 2003 profits for German chemicals group Degussa, which implemented heavy restructuring to reduce production capacity in its fine chemicals unit.
GEA buys up processing operations
09-Mar-2004 - German processing technology group GEA has announced new acquisitions that will increase its offering to the food and pharma industries, part of a new strategy to expand the business under parent company mg technologies.
Fending off the pharma copycats
08-Mar-2004 - Pharmaceutical companies must start exploring ways of extending patents on their products early in their lifecycle, such as developing improved formulations of the active ingredient, even before they are launched onto the market.
Regulatory & Safety: Most Popular...
Spotlight
  ICH sends Q11 guidelines to EU, US & Japanese regulatorsThe ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union... |
  in-Pharmatechnologist.com's review of Interphex 2012in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak... |
 Effective controls still lacking for continuous processing says Interphex panelContinuous processing is still hamstrung by a lack of control systems and is not ready for specific... |
 BASF buys omega-3 maker Equateq citing pharma potentialBASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key... |
 EMA outlines manufacturing quality docs for biologics trialsThe EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials. |